These findings are supported by our study results exhibiting that visfatin stimulated PI3K, Akt, and mTOR phosphorylation, while their respective pharmacologic inhibitors inhibit visfatin-induced increases in PDGF-C expression and promotion of chondrosarcoma angiogenesis, as do the genetic siRNAs. The gene discussed is PDGFC; the disease is chondrosarcoma.